Monday, 10 March 2014

Mice feeling the pain

BACKGROUND:Multiple sclerosis (MS), a demyelinating disease of the central nervous system, is one of the most prevalent neurological disorders in the industrialized world. This disease afflicts more than two million people worldwide, over two thirds of which are women. MS is typically diagnosed between the ages of 20-40 and can produce debilitating neurological impairments including muscle spasticity, muscle paralysis, and chronic pain. Despite the large sex disparity in MS prevalence, clinical and basic research investigations of how sex and oestrous cycle impact development, duration, and severity of neurological impairments and pain symptoms are limited. To help address these questions, we evaluated behavioral signs of sensory and motor functions in one of the most widely characterized animal models of MS, the experimental autoimmune encephalomyelitis (EAE) model.
METHODS:C57BL/6 male and female mice received flank injection of complete Freund's adjuvant (CFA) or CFA plus myelin oligodendrocyte glycoprotein 35-55 (MOG35-55) to induce EAE. EAE-induced neurological motor deficits including gait analysis and forelimb grip strength were assessed. Neuropathic pain-like behaviors evaluated included sensitivity to mechanical, cold, and heat stimulations. Oestrous cycle was determined daily via vaginal lavage.
RESULTS: MOG35-55-induced EAE produced neurological impairments (i.e., motor dysfunction) including mild paralysis and decreases in grip strength in both females and males. MOG35-55 produced behavioral signs of neuropathic pain--mechanical and cold hypersensitivity--in females, but not males. MOG35-55 did not change cutaneous heat sensitivity in either sex. Administration of CFA or CFA + MOG35-55 prolonged the time spent in dioestrus for 2 weeks, after which normal cycling returned. MOG35-55 produced fewer neurological motor deficits when mice were in proestrus relative to non-proestrus phases.
CONCLUSIONS: We conclude that female mice are superior to males for the study of neuropathic pain-like behaviors associated with MOG35-55-induced EAE. Further, proestrus may be protective against EAE-induced neurological deficits, thus necessitating further investigation into the impact that oestrous cycle exerts on MS symptoms.
Use of EAE is getting more and more difficult by the minute as it is an unpleasant disease.  Bring in pain to the equation and it increases the problems. This study suggests that there were pain-like responses in some animals with EAE, but they appeared along with neurological problems. 

Problem is mice don't speak and you have to look at behaviours one is to look into their eyes to see if they have "pain faces" others are withdrawal responses from an unpleasant stimulus, such as heat or cold. The problem is when you are doing this to paralysed limbs...can they feel it can they move from it. This is a problem. 

Suggesting neuropathic pain problems generated over years of MS is like a day of the first attack is comparing Chalk and Cheese.


  1. MD are you going to stop EAE experiments because of this finding? Are you surprised? MSers have pain.

  2. No, but it is fuel for those that want to stop EAE experiments. This is because all that people do is read the punchline. i.e EAE causes neuropathic pain. Whilst in some instances it may be that animals are experiencing pain, in other instances animals are anaesthetic and probably lack the sensation and so don't move away from the stimulus. In other cases they may be super sensitive.

    I fully accept that MSers have pain and quick a lot of MSers have pain and we need to develop better pain killers, but if we are to try and use animals to help inform about human problems we have to ask the right questions such that you can properly justify any pain caused.

    However this chalk and Cheese


Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.